Patents
Patents for C07C 327 - Thiocarboxylic acids (5,460)
04/2003
04/23/2003EP0904264B1 Compositions for increasing the mri contrast in visualising the digestive tract of patients
04/23/2003EP0669978B1 Flk-1 is a receptor for vascular endothelial growth factor
04/23/2003CN1106371C Liquid crystal compounds having perfluoroether terminal portions
04/22/2003US6551802 Genetic engineering
04/17/2003US20030073671 Side effect reduction; hormone replacement therapy
04/16/2003CN1105703C Alpha-substituted phenylacetic acid derivative, process for producing same, and agricultural bactericide containing same
04/15/2003WO2002036538A1 Process for producing esterificated condensate
04/15/2003US6548548 Cardiovascular disorders; anticholesterol agents
04/15/2003US6548526 Isothiazole derivatives useful as anticancer agents
04/15/2003CA2426000A1 Method for preparing ester condensate
04/10/2003US20030069225 Synthesis of taxol enhancers
04/08/2003US6544499 Polysiloxane or silicone resin, a linker, and a molecular hook for treating amino acid based substrates; hair care
04/08/2003CA2101423C Benzamides
04/03/2003US20030065146 Compound for use in the treatment of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease and sepsis
04/02/2003EP1296946A1 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
04/02/2003EP1296941A2 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants
04/02/2003EP0741694B1 Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them
04/02/2003CN1104410C Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them
04/01/2003US6541667 Mixing a nitrile with an aqueous solution comprising a sulfide and water
04/01/2003US6541656 Reacting an alpha, beta unsaturated carboxylic acid ester with a heterocyclic oxygen nitrogen, or sulfur compound
03/2003
03/27/2003WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents
03/26/2003EP1295868A1 Amide compounds and use thereof
03/26/2003EP1295866A1 4-membered ring compound and optical phase retardation plate using the same
03/26/2003CN1103775C Vitronectin receptor antagonists, their preparation and use
03/18/2003US6534493 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
03/13/2003WO2003020690A1 Aryl sulfamate derivatives
03/13/2003WO2002097393A3 Cleavable surfactants and methods of use thereof
03/13/2003US20030050324 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
03/12/2003EP0672031B1 Catechol diethers as selective pde iv inhibitors
03/06/2003US20030045518 Certain bis(thio-hydrazide amide) compounds significantly enhance the anticancer activity of taxol.
03/05/2003EP1286956A1 Phenyl-substituted 2-enamino-keto nitriles
03/05/2003EP0939628B1 Thiol sulfone metalloprotease inhibitors
03/05/2003EP0853610B1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
03/04/2003US6528528 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
02/2003
02/27/2003WO2002068592A3 Non-racemic hexafluoreleucine, and methods of making and using it
02/27/2003US20030040460 For use in cologne, a soap, a shower or bath gel, a shampoo or hair-care product, a cosmetics, a body or ambient air deodorant, a detergent or a fabric softener, or a household product; dessert, ice-cream, candy, beverage, fruit jam
02/26/2003EP1285652A1 Novel fatty acid analogues for the treatment of hypertension
02/20/2003WO2003014073A1 Fatty acid compounds, preparation and uses thereof
02/20/2003US20030036558 Useful in the treatment of chronic complications arising from diabetes, such as neuropathy; may also contain an angiotensin converting enzyme inhibitor.
02/20/2003CA2456288A1 Fatty acid compounds, preparation and uses thereof
02/19/2003EP1284139A1 Novel fatty acid analogues for the treatment of fatty liver
02/19/2003EP1283842A1 Radiopharmaceutical products suitable for the selective labeling of lymphocytes, and their preparation
02/19/2003CN1101806C Novel gem-difluoro derivatives of phenylacetemide-and phenylacetic acid and their pharmaceutical uses
02/18/2003US6521624 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
02/13/2003US20030032644 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
02/10/2003WO2002014263A1 Acylacetonitriles, process for preparation thereof and miticides containing the same
02/06/2003WO2002046172A3 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
02/06/2003WO2002046141A3 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis
02/06/2003US20030027807 Vitronectin receptor antagonists, their preparation and their use
02/05/2003EP1280764A2 Inhibitors of histone deacetylase
02/05/2003CN1394846A Alpha-substituted benzene acetic acid its preparation and farm pesticide containing said compound
01/2003
01/29/2003EP1279662A1 Process for preparing phenylcyclohexan-1-ylcarboxylic acids
01/29/2003CN1100031C Cyclohexane derivatives
01/28/2003US6512081 Synthesis of dithioester chain transfer agents and use of bis(thioacyl) disulfides or dithioesters as chain transfer agents
01/28/2003US6511990 Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
01/28/2003CA2124375C Compounds containing a fused bicyclic ring and processes therefor
01/27/2003WO2002010127A1 Acetamide derivatives and the use thereof as inhibitors of coagulation factors xa and viia
01/27/2003CA2417427A1 Acetamide derivatives and the use thereof as inhibitors of coagulation factors xa and viia
01/23/2003WO2003006430A1 Taxol enhancer compounds
01/23/2003WO2003006429A1 Synthesis of taxol enhancers
01/23/2003WO2003006428A1 Taxol enhancer compounds
01/23/2003WO2003005959A2 Amphiphilic star-like macromolecules for drug delivery
01/23/2003CA2453415A1 Synthesis of taxol enhancers
01/23/2003CA2453216A1 Amphiphilic star-like macromolecules for drug delivery
01/22/2003CN1392144A 3-amino-2-mercapto phenyl formic acid erivative and its preparation
01/16/2003US20030013903 Process for crystallization of 2-acetylthio-3-phenyl-propionic acid
01/16/2003US20030013763 Controlling blood glucose concentration
01/16/2003US20030013748 Anticancer agents
01/16/2003US20030013713 Compounds as PDE IV and TNF-inhibitors
01/15/2003EP1275642A1 Process for crystallization of 2-acetylthio-3-phenyl-propionic acid
01/14/2003US6506786 HIV protease inhibitors based on amino acid derivatives
01/14/2003US6506286 Reactant, compound and process for the perfluoroalkylation of a nucleophile, and the derivatives obtained
01/09/2003WO2003002491A2 ENANTIOSELECTIVE TRANSFORMATION OF α, β-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS
01/09/2003WO2002081437A3 Novel n-p-propargyloxyphenethyl-thioacetic acid amides
01/08/2003EP1272466A1 Method for the preparation of (s)-2-acetylthio-3-phenylpropionic acid
01/08/2003EP1272457A2 Compounds for modulating cell proliferation
01/08/2003EP1272452A2 Process for the preparation of (r)-2-bromo-3-phenyl-propionic acid
01/08/2003EP0866056B1 N- (fluoroalkoxy)phenoxyalkyl]benzamide compounds, intermediates thereof, process for producing the same, and agricultural and horticultural pesticides
01/07/2003US6504049 Process for synthesizing pharmaceutically active disulfide salts
01/03/2003WO2003000643A1 Nitrate ester derivatives useful for preparing drugs for epilepsy
01/02/2003EP1270728A1 Process for producing avermectin derivative
12/2002
12/31/2002US6500832 Administering enzyme inhibitors as viricides for prophylaxis of viral diseases such as aquired immune deficiency syndrome
12/27/2002WO2002103103A2 Fluorine-containing compounds and polymers derived therefrom
12/27/2002WO2002102758A1 Fluorine-containing compounds and polymers derived therefrom
12/27/2002WO2002046181A3 Abca-1 elevating compounds against coronary artery disease or atherosclerosis
12/27/2002CA2451547A1 Fluorine-containing compounds and polymers derived therefrom
12/27/2002CA2451542A1 Fluorine-containing compounds and polymers derived therefrom
12/26/2002US20020198376 As therapeutic agents for autoimmune diseases such as rheumatoid arthritis
12/26/2002US20020198259 Treatment of disease caused by procedural vascular trauma and/or an increased level of plasma homocysteine
12/26/2002US20020198184 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis
12/24/2002US6498265 3-amino-2-mercaptobenzoic acid derivatives and processes for their preparation
12/24/2002US6498253 Acylated aminophenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators
12/24/2002CA2150812C Catechol diethers as selective pde iv inhibitors
12/19/2002US20020193596 Inhibitors of protein isoprenyl transferases
12/18/2002EP1265850A2 Insecticidal anthranilamides
12/18/2002EP0736002B9 Compound capable of introducing at least one molecule into a cell
12/17/2002US6495607 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
12/12/2002WO2002098849A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
12/12/2002WO2002098841A1 Insecticidal biphenylthiohydrazides
12/12/2002WO2002098241A1 Flavour and fragrance compositions
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 ... 55